Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
- D. Cooper, G. Doherty, R. Tuttle
- Medicine, BiologyThyroid
- 4 November 2009
Evidence-based recommendations in response to the appointment as an independent task force by the American Thyroid Association to assist in the clinical management of patients with thyroid nodules and differentiated thyroid cancer represent, in the authors' opinion, contemporary optimal care for patients with these disorders.
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
- D. Cooper, G. Doherty, R. Tuttle
- MedicineThyroid
- 14 March 2006
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.
- S. Wilhelm, Tracy S. Wang, S. Carty
- MedicineJAMA Surgery
- 1 October 2016
Evidence-based recommendations were created to assist clinicians in the optimal treatment of patients with pHPT to develop evidence-based guidelines to enhance the appropriate, safe, and effective practice of parathyroidectomy.
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid…
- B. Haugen, E. Alexander, L. Wartofsky
- Medicine, BiologyThyroid
- 1 November 2009
Evidence-based recommendations are developed to inform clinical decision-making in the management of thyroid nodules and differentiated thyroid cancer and represent, in the authors' opinion, contemporary optimal care for patients with these disorders.
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1
- U. Liyanage, T. Moore, D. Linehan
- Biology, MedicineJournal of Immunology
- 1 September 2002
It is concluded that the prevalence of Treg is increased in the peripheral blood as well as in the tumor microenvironment of patients with invasive breast or pancreas cancers, and may partly explain the poor immune response against tumor Ags.
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis
- T. Giordano, R. Kuick, Y. Nikiforov
- BiologyOncogene
- 6 October 2005
It is demonstrated that mutational status is the primary determinant of gene expression variation within these tumors, a finding that may have clinical and diagnostic significance and predicts success for therapies designed to prevent the consequences of these mutations.
Management of patients with adrenal cancer: recommendations of an international consensus conference.
- D. Schteingart, G. Doherty, F. Worden
- Medicine, BiologyEndocrine-Related Cancer
- 1 September 2005
A consensus conference was organized and held at the University of Michigan in Ann Arbor, MI, 11-13 September 2003, with the participation of an international group of physicians who had reported on the largest series of patients with this disease and who had recognized basic and clinical research expertise in adrenal cortical cancer.
Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
- T. Giordano, R. Kuick, G. Hammer
- BiologyClinical Cancer Research
- 15 January 2009
This study lays the foundation for the molecular classification and prognostication of adrenocortical tumors and also provides a rich source of potential diagnostic and prognostic markers.
Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.
- S. Carty, D. Cooper, R. Udelsman
- Medicine, BiologyThyroid
- 4 November 2009
Central neck dissection at a minimum should consist of removal of the prelaryngeal, pretracheal, and paratracheAL lymph nodes.
Central Lymph Node Dissection in Differentiated Thyroid Cancer
- M. L. White, P. Gauger, G. Doherty
- Medicine, BiologyWorld Journal of Surgery
- 2 March 2007
Evidence-based recommendations support CLND for PTC in patients under the care of experienced endocrine surgeons, supporting a more aggressive initial operation.
...
...